Metrion Biosciences and LifeArc Sign Collaborative Agreement for Neuroscience-Focused Ion Channel Drug Discovery
Novel small molecule programme aims to address major unmet medical need in neuroscience
Novel small molecule programme aims to address major unmet medical need in neuroscience
From CRISPR screening to CRISPR/Cas9-edited fusion proteins, we discover the latest technology, news and products in gene editing technology
Relive the biggest stories of the month and find out what’s been making waves in the SelectScience life sciences community since the turn of the year
Dr. Jim Aguanno explores the role of natriuretic peptides – NT-proBNP and BNP – in the diagnosis of heart failure
Beckman Coulter Life Sciences has announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden
New circulating cooler with CO2 more than three thousand times less damaging than conventional refrigerants
Learn how inert-glass vials can secure your sophisticated ultra-trace analysis
Miltenyi Biotec will showcase a fully-automated flow cytometry screening set-up at SLAS booth #316
Visit BrandTech at Booth 336 to see new Liquid Handling Station flow pipetting robot
Porvair Sciences reports on a highly effective protocol for preparing cannabis samples for analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Visit booth 1413 at the SLAS2019 conference in Washington D.C., USA, to pick up a limited edition T-shirt in exchange for a 2-minute lab product review – there are four fab designs to choose from
Agilent set to display a brand-new metabolomics-specific sample preparation solution
Functional genomic screening using CRISPR-Cas9 gene editing technology for drug discovery, development and more
DeNovix Inc. introduces the first imaging cell counter to remove the need for slides or plastic consumables
The THUNDER imager family enables users to decode 3D biology in real-time*
Scientists from the esteemed Institute for Genetic Medicine, Newcastle, UK, are using sophisticated consumable technologies to advance research into rare mitochondrial diseases